US 9623088
Factor VIII polypeptide formulations
granted A61KA61K38/37A61P
Quick answer
US patent 9623088 (Factor VIII polypeptide formulations) held by BIOVERATIV THERAPEUTICS INC. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K38/37, A61P, A61P43/00, A61P7/00